Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 57

    Health Ministry undertakes largest ever drug survey in the world for determining the quality of drugs

    Health Ministry undertakes largest ever drug survey in the world for determining the quality of drugs

    savita thakur thakur24 Feb 2017 10:44 AM IST
    The Ministry of Health and Family Welfare, Government of India had entrusted the work relating to carrying out a Survey of the extent of Problems of...
    NPPA warns stent makers, importers against shortage

    NPPA warns stent makers, importers against shortage

    supriya kashyap kashyap23 Feb 2017 10:27 AM IST
    New Delhi : Drug pricing regulator NPPA has asked stent makers and importers to ensure that production as well as supply of stents remains at the...
    Pharma industry to reach $55 bn in 3 years: Study

    Pharma industry to reach $55 bn in 3 years: Study

    supriya kashyap kashyap21 Feb 2017 2:22 PM IST
    New Delhi : Indian pharmaceuticals market is expected to touch 55 billion dollars by 2020 from the current level of 36.7 billion dollars in 2016...
    After Cardiac Stents; Otho Implants, Intraocular Lenses, Heart Valves etc in for price Cap

    After Cardiac Stents; Otho Implants, Intraocular Lenses, Heart Valves etc in for price Cap

    savita thakur thakur20 Feb 2017 2:15 PM IST
    New Delhi: Moving ahead with its price capping policy, it is expected that the National Pharmaceutical Pricing Authority (NPPA) will be capping the...
    Can Biocon, Mylan drugs be used for early breast cancer, asks Delhi HC

    Can Biocon, Mylan drugs be used for early breast cancer, asks Delhi HC

    supriya kashyap kashyap18 Feb 2017 3:02 PM IST
    New Delhi : Can pharma majors Biocon and Mylan's generic breast cancer drugs, similar to that of their competitor Roche, be prescribed for early...
    Firms creating artificial shortage of stents, Govt Threatens Action

    Firms creating artificial shortage of stents, Govt Threatens Action

    supriya kashyap kashyap17 Feb 2017 5:06 PM IST
    New Delhi : Government said it is keeping a close watch on some companies trying to create an artificial shortage of life-saving coronary stents and...
    AiMeD wants govt to mandate Buy in India for devices with 50 percent price benefit for Indian products

    AiMeD wants govt to mandate Buy in India for devices with 50 percent price benefit for Indian products

    supriya kashyap kashyap16 Feb 2017 10:43 AM IST
    Association of Indian Medical Device Industry (AiMeD) is of the view that since the government health departments are the largest purchaser of medical...
    Thailand seeks investments from India in biotech, electronics

    Thailand seeks investments from India in biotech, electronics

    supriya kashyap kashyap13 Feb 2017 5:05 PM IST
    New Delhi : Seeking investments from India in areas like automation, smart electronics and biotech, Thailand Board of Investment has said that the...
    Govt to amend norms to empower NPPA to fix prices of 350 drugs

    Govt to amend norms to empower NPPA to fix prices of 350 drugs

    supriya kashyap kashyap13 Feb 2017 11:12 AM IST
    Bengaluru : The government said it will soon amend norms to empower National Pharmaceutical Pricing Authority (NPPA) to regulate about 350 medicines...
    India pharma exports may see near double-digit growth in FY17: Official

    India pharma exports may see near double-digit growth in FY17: Official

    supriya kashyap kashyap11 Feb 2017 9:58 AM IST
    Hyderabad : Indian pharma exports in the current financial year may see a near double-digit growth and might end up on the lines with that of last...
    DOP directes NPPA to refix the price of Phenobarbitone 30 mg and Sodium Valprorate 200 mg tablets

    DOP directes NPPA to refix the price of Phenobarbitone 30 mg and Sodium Valprorate 200 mg tablets

    savita thakur thakur10 Feb 2017 10:05 AM IST
    The Department of Pharmaceuticals (DoP) has directed the National Pharmaceutical Pricing Authority (NPPA) to examine the data/information once again...
    FDA approves drug to treat Duchenne muscular dystrophy

    FDA approves drug to treat Duchenne muscular dystrophy

    supriya kashyap kashyap10 Feb 2017 9:59 AM IST
    The U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok